The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2020

Filed:

Jan. 23, 2015
Applicants:

Km Biologics Co., Ltd., Kumamoto, JP;

National University Corporation Kumamoto University, Kumamoto, JP;

Inventors:

Akihiko Hosoi, Kumamoto, JP;

Masaharu Torikai, Kumamoto, JP;

Tomoyo Takeo, Kumamoto, JP;

Masayo Ueno, Kumamoto, JP;

Hirofumi Higuchi, Kikuchi, JP;

Kenji Soejima, Kumamoto, JP;

Toshihiro Nakashima, Kumamoto, JP;

Yukio Ando, Kumamoto, JP;

Hirofumi Jono, Kumamoto, JP;

Yu Su, Shanghai, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 39/395 (2006.01); G01N 33/68 (2006.01); A61K 39/00 (2006.01); C07K 14/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 39/0007 (2013.01); G01N 33/6896 (2013.01); A61K 2039/505 (2013.01); C07K 14/00 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2333/47 (2013.01); G01N 2800/28 (2013.01); G01N 2800/7047 (2013.01);
Abstract

A humanized antibody which comprises a complementarity determining region of an H chain consisting of the amino acid sequence as shown in SEQ ID NOs: 1 to 3 and a complementarity determining region of an L chain consisting of the amino acid sequence as shown in SEQ ID NOs: 4 to 6. The humanized antibody of the present invention has the activity to specifically bind to transthyretin (TTR) with structural change and the activity to inhibit fibrillization of TTR and is a humanized antibody suitable for application to human body.


Find Patent Forward Citations

Loading…